CEPHEUS demonstrated higher MRD negativity with daratumumab-hyaluronidase plus VRd versus VRd (52.3% vs 34.8%; P=.0005), supporting use in transplant-ineligible newly diagnosed patients. PFS benefit ...
Abstract: The evolution of wireless communications has been significantly influenced by remarkable advancements in multiple access (MA) technologies over the past five decades, shaping the landscape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results